We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 14

Celebrity endorsements blamed for kids’ “junk” food choices

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • March 15 2013

A University of Liverpool study contends that "celebrity endorsement of a food product encourages children to eat more of the endorsed product." The

WTO Appellate Body rules against U.S. Country of Origin Labeling

  • Hogan Lovells
  • -
  • Global, USA
  • -
  • July 18 2012

The World Trade Organization (WTO) Appellate Body has issued a ruling upholding an earlier WTO Panel finding that the United States’ Country of Origin Labeling (COOL) requirements for beef and pork muscle cuts violate WTO rules because the U.S. COOL scheme discriminates against imported livestock

Outside of FDA

  • Drinker Biddle & Reath LLP
  • -
  • European Union, Global, United Kingdom, USA
  • -
  • June 30 2008

The European Directorate for the Quality of Medicines & HealthCare (EDQM, Council of Europe), recently met with the Ministry of Health of India and the Indian Pharmacopoeia Commission (IPC) to discuss improving the quality and safety of medicines in both locations, and developing joint inspections of DBR Reg Sci May - June 2008 Page 7 manufacturing sites

WTO panel issues preliminary ruling against COOL

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • June 17 2011

The World Trade Organization (WTO) has reportedly issued a preliminary ruling that U.S. country-of-origin labeling (COOL) laws violate the organization’s Agreement on Technical Barriers to Trade

WTO nixes “dolphin-safe” labels on U.S. tuna

  • Shook Hardy & Bacon LLP
  • -
  • Global, Mexico, USA
  • -
  • September 16 2011

Concluding that “dolphin-safe” tuna product labels authorized by the U.S. Commerce Department “are more trade-restrictive than necessary to achieve a legitimate objective,” a World Trade Organization (WTO) panel has given a partial victory to Mexico, which filed a complaint in 2009 claiming that the labels were illegal because they excluded Mexican yellowfin tuna from the U.S. market and shut down one-third of its tuna fleet

Regulators continue to address radiation concerns

  • Shook Hardy & Bacon LLP
  • -
  • Global, Japan, USA
  • -
  • March 25 2011

The World Health Organization (WHO), U.S. Food and Drug Administration (FDA) and U.S. Department of Agriculture (USDA) have continued to address public concerns about food produced in Japan, where a recent earthquake and tsunami compromised the Fukushima prefecture’s nuclear power plant, releasing radiation into the atmosphere

FDA prepares for international meeting on cosmetics regulations

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • April 14 2011

The Food and Drug Administration (FDA) has scheduled an April 26, 2011, meeting in Rockville, Maryland, to discuss topics that will be addressed by a voluntary international group of cosmetics regulatory authorities June 28-July 1 in Paris, France

WTO rebuffs U.S. COOL regulations

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • December 2 2011

A World Trade Organization (WTO) panel has issued a ruling against the United States in a dispute with Mexico and Canada over country-of-origin labeling (COOL) regulations for beef and pork products

Global Pricing Newsletter: volume two

  • Sidley Austin LLP
  • -
  • China, Global, United Kingdom, USA
  • -
  • February 27 2013

Pharmaceutical and biologic manufacturers operate in an increasingly global economy where legal developments in one market may have cascading impacts

IOM publishes report on the effects of falsified and substandard medicines

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • February 21 2013

At the request of the U.S. Food and Drug Administration (FDA), national think tank the Institute of Medicine (IOM) has published a report that